Detalhe da pesquisa
1.
Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization.
Arterioscler Thromb Vasc Biol
; 44(1): 177-191, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38150518
2.
Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart.
Am J Physiol Endocrinol Metab
; 321(6): E753-E765, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34747201
3.
Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with "Corner Fractures".
Am J Hum Genet
; 101(5): 815-823, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100092
4.
Flow-Induced Secretion of Endothelial Heparanase Regulates Cardiac Lipoprotein Lipase and Changes Following Diabetes.
J Am Heart Assoc
; 11(23): e027958, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36416172